Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

MRI-Based radiomic signature for predicting pathologic treatment response to neoadjuvant chemoradiotherapy and radioimmunotherapy in soft tissue sarcoma.

Skeletal radiology·2026
Same author

Mapping the Burden of Hypertension in Türkiye (2008-2022): A National Cross-Sectional Study of Nearly 100000 Adults.

International journal of hypertension·2026
Same author

Pediatric Reference Ranges for Glomerular Filtration Rate Determined by a Single Injection of <sup>99m</sup>Tc-DTPA.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Accuracy comparison of 4D computed tomography (4DCT) and 4D cone beam computed tomography (4DCBCT).

International journal of medical physics, clinical engineering and radiation oncology·2026

Related Experiment Video

Updated: Jun 8, 2026

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images
08:02

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images

Published on: November 15, 2024

Variability in PET quantitation within a multicenter consortium.

Frederic H Fahey1, Paul E Kinahan, Robert K Doot

  • 1Department of Radiology, Division of Nuclear Medicine, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA. frederic.fahey@childrens.harvard.edu

Medical Physics
|September 14, 2010
PubMed
Summary
This summary is machine-generated.

Multicenter positron emission tomography (PET) quantitation showed significant variability in standard uptake value (SUV) measurements. Centralized analysis and quality control significantly reduced SUV variability, essential for multicenter pediatric brain tumor research.

More Related Videos

Species Determination and Quantitation in Mixtures Using MRM Mass Spectrometry of Peptides Applied to Meat Authentication
09:26

Species Determination and Quantitation in Mixtures Using MRM Mass Spectrometry of Peptides Applied to Meat Authentication

Published on: September 20, 2016

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

Related Experiment Videos

Last Updated: Jun 8, 2026

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images
08:02

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images

Published on: November 15, 2024

Species Determination and Quantitation in Mixtures Using MRM Mass Spectrometry of Peptides Applied to Meat Authentication
09:26

Species Determination and Quantitation in Mixtures Using MRM Mass Spectrometry of Peptides Applied to Meat Authentication

Published on: September 20, 2016

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

Area of Science:

  • Medical Imaging
  • Nuclear Medicine
  • Pediatric Oncology

Background:

  • Positron emission tomography (PET) is crucial for pediatric brain tumor research.
  • Standardized quantitation is essential for multicenter studies.
  • Variability in PET data can impact treatment efficacy assessment.

Purpose of the Study:

  • To evaluate quantitation variability in PET data across a multicenter consortium.
  • To identify sources of variability in PET imaging and analysis.
  • To establish quality control measures for multicenter PET studies.

Main Methods:

  • Utilized American Association of Physicists in Medicine/Society of Nuclear Medicine Task Group 145 PET quantitation phantoms.
  • Ten sites within the Pediatric Brain Tumor Consortium (PBTC) performed phantom imaging.
  • Analyzed Standard Uptake Value (SUV) and recovery coefficients (RC) from local and central analyses.

Main Results:

  • Local site SUV measurements showed high variability (COV 29.9%-42.8%).
  • Centralized analysis reduced SUV variability (COV 7.7%-23.2%).
  • Correcting miscalculations and using mean SUV in central analysis further reduced variability (COV 8.8%-18.4%).

Conclusions:

  • SUV variability of 10%-25% is expected from instrument and analysis factors in multicenter PET studies.
  • Centralized reading and robust quality assurance are critical for minimizing variability.
  • Overall SUV variability will be higher due to biological and protocol factors.